首页> 美国卫生研究院文献>other >Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

【2h】

Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

机译：蛋白尿与血管内皮生长因子受体酪氨酸激酶抑制剂相关的癌症患者的风险：系统评价和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundVascular endothelial growth factor tyrosine-kinase inhibitors (VEGFR-TKIs) have emerged as an effective targeted therapy in the treatment of cancer patients, the overall incidence and risk of proteinuria associated these drugs is unclear. We performed a systematic review and meta-analysis of published clinical trials to quantify the incidence and risk of proteinuria associated with VEGFR-TKIs.

机译：背景技术血管内皮生长因子酪氨酸激酶抑制剂（VEGFR-TKIs）已经成为治疗癌症患者的有效靶向疗法，这些药物的总发生率和蛋白尿相关风险尚不清楚。我们对已发表的临床试验进行了系统的回顾和荟萃分析，以量化与VEGFR-TKIs相关的蛋白尿的发生率和风险。

著录项

期刊名称 other
作者
Ze-Feng Zhang; Tao Wang; Li-Hua Liu; Hui-Qin Guo;
展开▼
作者单位

展开▼
年(卷),期 -1(9),3
年度 -1
页码 e90135
总页数 10
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis [J] . QiW.-X., SunY.-J., TangL.-N., Critical reviews in oncology/hematology . 2014,第3期

机译：血管内皮生长因子受体酪氨酸激酶抑制剂治疗的癌症患者胃肠道穿孔的风险：系统评价和荟萃分析
2. Hand-foot skin reaction with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis [J] . Jing Li, Jian Gu Critical reviews in oncology/hematology . 2017,第期

机译：癌症患者中血管内皮生长因子受体酪氨酸激酶抑制剂的手脚皮肤反应：系统审查和荟萃分析
3. Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials [J] . Qi Wei-Xiang, Shen Zan, Tang Li-Na, British Journal of Clinical Pharmacology . 2014,第4期

机译：血管内皮生长因子酪氨酸激酶抑制剂治疗的癌症患者的充血性心力衰竭风险：36项临床试验的系统评价和荟萃分析
4. QSAR Study of Quinazoline Derivatives as Inhibitor of Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK) [C] . La Ode Aman, Widisusanti Abdulkadir, Julitha Geybie Rembet, International Conference on Computation for Science and Technology . 2015

机译：喹唑啉衍生物作为表皮生长因子受体 - 酪氨酸激酶（EGFR-TK）抑制剂的QSAR研究
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials [O] . Wei-Xiang Qi, Zan Shen, Li-Na Tang, 2014

机译：血管内皮生长因子酪氨酸激酶抑制剂治疗的癌症患者的充血性心力衰竭风险：36项临床试验的系统评价和荟萃分析
7. Risks of proteinuria associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a systematic review and meta-analysis. [O] . Ze-Feng Zhang, Tao Wang, Li-Hua Liu, 2014

机译：癌症患者中与血管内皮生长因子受体酪氨酸激酶抑制剂相关的蛋白尿风险：系统评价和荟萃分析。

Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

摘要

著录项

相似文献

相关主题

期刊订阅